CASE STUDY PRA’s Optimal Recruitment Strategies Reduce Enrollment Timelines A Focus on Emerging Markets for Recruitment Success in Breast Cancer StudiesPRA’s Optimal Recruitment Strategies Reduce Enrollment Timelines A Focus on Emerging Markets for Recruitment Success in Breast Cancer Studies Primary Endpoint Time-to-response PRA Services Regulatory Submission Document Management Project Management Drug Safety Reporting Monitoring & Recruitment Feasibility Medical Monitoring Vendor Management Trial Logistics Indication Thrombocytopenia Drug Class Chemical Entity Study Phase III Business Segment Product Registration Regions Eastern Europe Russia STUDY DESCRIPTION A Phase III trial comparing drug treatments in patients with advanced breast cancer previously treated wit

Join for free to read